|Last Price$51.39||Day Change (%)0%|
|Open Price$51.77||Day Change ($)0.00|
|Day Range51.12–51.84||52-Week Range32.00–57.52|
As of Mon 07/21/2014 07:05 PM EST | USD
Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction
Mylan Laboratories MYL reported impressive second-quarter results Wednesday. However, most of the improvement was temporary and will not affect our fair value estimate. The quarter was only slightly better than we expected after excluding a one-time litigation payment and proceeds from a product ...
Roche Not Interested in Large Acquisitions, Says CEO -- Report
Obama urges immediate action on 'inversions'
UPDATE: Tesla, Citigroup gain; GoPro tumbles
UPDATE: U.S. stocks: Dow tops 17,000, eyes record close
MARKET SNAPSHOT: U.S. Stocks: Dow Tops 17,000, Eyes Record Close
As credit spreads have tightened on a nearly continuous trend over the past year, they are becoming richly valued relative to their historical average.
Plus, a top executive bolts from eBay, Brazilian telcos get cheap, and more.
Biotech companies' returns have diverged from the broader market in recent weeks amid concerns over greater regulation and price discounting.